BR9502647A - Derivado de 3-heteroalifatil-e-3-hetero(aril)alifatil-2(1h)-quinolona e processo para sua preparação preparo farmacêutico uso dos ditos derivados e processo para o tratamento de doenças convulsivas - Google Patents
Derivado de 3-heteroalifatil-e-3-hetero(aril)alifatil-2(1h)-quinolona e processo para sua preparação preparo farmacêutico uso dos ditos derivados e processo para o tratamento de doenças convulsivasInfo
- Publication number
- BR9502647A BR9502647A BR9502647A BR9502647A BR9502647A BR 9502647 A BR9502647 A BR 9502647A BR 9502647 A BR9502647 A BR 9502647A BR 9502647 A BR9502647 A BR 9502647A BR 9502647 A BR9502647 A BR 9502647A
- Authority
- BR
- Brazil
- Prior art keywords
- heteroalifatil
- alifatyl
- quinolone
- hetero
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH173294 | 1994-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9502647A true BR9502647A (pt) | 1996-04-23 |
Family
ID=4217306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9502647A BR9502647A (pt) | 1994-06-02 | 1995-06-02 | Derivado de 3-heteroalifatil-e-3-hetero(aril)alifatil-2(1h)-quinolona e processo para sua preparação preparo farmacêutico uso dos ditos derivados e processo para o tratamento de doenças convulsivas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5633379A (pt) |
| EP (1) | EP0685466A1 (pt) |
| JP (1) | JPH0841027A (pt) |
| KR (1) | KR960000868A (pt) |
| CN (1) | CN1120538A (pt) |
| AU (1) | AU2033695A (pt) |
| BR (1) | BR9502647A (pt) |
| CA (1) | CA2150645A1 (pt) |
| FI (1) | FI952650A (pt) |
| HU (1) | HUT72608A (pt) |
| IL (1) | IL113975A0 (pt) |
| NO (1) | NO952171L (pt) |
| NZ (1) | NZ272258A (pt) |
| RU (1) | RU95109098A (pt) |
| ZA (1) | ZA954507B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2943725B2 (ja) | 1996-01-17 | 1999-08-30 | 大日本インキ化学工業株式会社 | キノリノン誘導体及びそれを有効成分とする抗アレルギー剤 |
| DE19601782A1 (de) * | 1996-01-19 | 1997-07-24 | Merck Patent Gmbh | Chinolin-2-(1H)one |
| DE69809827D1 (de) * | 1997-03-31 | 2003-01-16 | Korea Res Inst Chem Tech | Chinolinische Sulfid-Derivate als NMDA Rezeptor-Antagonisten und Verfahren zu ihrer Herstellung |
| KR100301129B1 (ko) * | 1997-11-06 | 2001-11-30 | 김충섭 | 3-(치환-페닐티오)-4-하이드록시퀴놀린-2(1h)-온 유도체 및 그들의 제조방법 |
| AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
| US6689791B2 (en) * | 2002-03-01 | 2004-02-10 | R. T. Alamo Ventures I, Llc | Carboxylated heterocyclic compounds and methods of synthesis |
| MX2009014216A (es) * | 2007-06-29 | 2010-07-05 | Univ Emory | Antagonistas del receptor nmda para neuroproteccion. |
| CN103508950B (zh) * | 2012-06-25 | 2016-04-20 | 南开大学 | 含亚胺结构的4-羟基-2-喹啉酮类化合物及其制备和应用 |
| AU2015308350B2 (en) | 2014-08-29 | 2020-03-05 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
| KR101847567B1 (ko) | 2015-12-24 | 2018-04-10 | 주식회사 포스코 | 미세하고 균일한 도금 조직을 갖는 도금 강판 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3847927A (en) * | 1972-12-20 | 1974-11-12 | Dow Chemical Co | Sulfur-containing hydroxypyridones |
| US4124587A (en) * | 1976-03-01 | 1978-11-07 | Sandoz, Inc. | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones |
| US4127574A (en) * | 1976-03-01 | 1978-11-28 | Sandoz, Inc. | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones |
| EP0459561B1 (en) * | 1990-05-31 | 1995-09-20 | MERCK SHARP & DOHME LTD. | Dioxo-tetrahydroquinoline derivatives |
| GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
| GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| SE469368B (sv) * | 1991-10-09 | 1993-06-28 | Kabi Pharmacia Ab | Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) |
| GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125485D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-05-23 EP EP95810344A patent/EP0685466A1/de not_active Withdrawn
- 1995-05-26 AU AU20336/95A patent/AU2033695A/en not_active Abandoned
- 1995-05-29 RU RU95109098/04A patent/RU95109098A/ru unknown
- 1995-05-31 CA CA002150645A patent/CA2150645A1/en not_active Abandoned
- 1995-05-31 NZ NZ272258A patent/NZ272258A/en unknown
- 1995-05-31 FI FI952650A patent/FI952650A/fi not_active Application Discontinuation
- 1995-06-01 KR KR1019950014478A patent/KR960000868A/ko not_active Application Discontinuation
- 1995-06-01 ZA ZA954507A patent/ZA954507B/xx unknown
- 1995-06-01 HU HU9501598A patent/HUT72608A/hu unknown
- 1995-06-01 CN CN95106179A patent/CN1120538A/zh active Pending
- 1995-06-01 IL IL11397595A patent/IL113975A0/xx unknown
- 1995-06-01 US US08/456,358 patent/US5633379A/en not_active Expired - Fee Related
- 1995-06-01 NO NO952171A patent/NO952171L/no unknown
- 1995-06-02 BR BR9502647A patent/BR9502647A/pt not_active Application Discontinuation
- 1995-06-02 JP JP7136724A patent/JPH0841027A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI952650A0 (fi) | 1995-05-31 |
| IL113975A0 (en) | 1995-10-31 |
| KR960000868A (ko) | 1996-01-25 |
| HU9501598D0 (en) | 1995-07-28 |
| NO952171L (no) | 1995-12-04 |
| CA2150645A1 (en) | 1995-12-03 |
| NZ272258A (en) | 1996-12-20 |
| FI952650A (fi) | 1995-12-03 |
| ZA954507B (en) | 1996-02-01 |
| HUT72608A (en) | 1996-05-28 |
| CN1120538A (zh) | 1996-04-17 |
| US5633379A (en) | 1997-05-27 |
| RU95109098A (ru) | 1997-03-10 |
| EP0685466A1 (de) | 1995-12-06 |
| JPH0841027A (ja) | 1996-02-13 |
| AU2033695A (en) | 1995-12-14 |
| NO952171D0 (no) | 1995-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9504509A (pt) | Composto processo para sua preparaçao e formulaçao farmaceûtica | |
| PT850948E (pt) | Derivados propiofenona e processo para a preparacao dos mesmos | |
| BR9708312A (pt) | Derivados de 4-amino-pirimidina medicamentos contendo esses compostos sua aplicação e processo para sua fabricação | |
| FR2722984B1 (fr) | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees | |
| BR9503638A (pt) | Composto processo para sua produção e formulação farmacêutica | |
| BR9507700A (pt) | Novos derivados da eritromicida proceso de preparação dos mesmos e aplicação dos mesmos como medicamentos | |
| BR9910900B1 (pt) | compostos derivados de isotiazol, processo para sua preparação e composição farmacêutica dos mesmos | |
| EE03380B1 (et) | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod | |
| MX9100529A (es) | Derivados substituidos de oxazolidindiona y proceso para su preparacion | |
| BR0017030B1 (pt) | derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos | |
| BR9601028A (pt) | Compostos processo para sua preparação processo para a produção de preparações farmacêuticas preparação farmacêutica medicamento e uso | |
| BR9606396A (pt) | Derivados de camptotecin substituídos e processo para sua preparação | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
| BR9504463A (pt) | Processo para preparaçao de lipossomas de quetoprofeno e preparaçoes farmacêuticas | |
| BR9506106A (pt) | Composto processo para sua preparação medicamento e composição farmacêutica | |
| BR9502647A (pt) | Derivado de 3-heteroalifatil-e-3-hetero(aril)alifatil-2(1h)-quinolona e processo para sua preparação preparo farmacêutico uso dos ditos derivados e processo para o tratamento de doenças convulsivas | |
| BR9600149A (pt) | 2-(2-N-alcoxifenil)-purin-6-onas 9-substituídas processo para sua preparação medicamantos e uso | |
| BR9504090A (pt) | Composição farmacêutica transdermicamente ativante processo para sua preparação e método de tratar câncer | |
| BR9505962A (pt) | Suspensão farmacêutica aquosa e processo para sua preparação | |
| MA23663A1 (fr) | Procede de preparation de formulations pharmaceutiques | |
| BR9605046A (pt) | Compostos preparação farmacêutica uso dos compostos e processo para a fabricação dos mesmos | |
| DE69706037D1 (de) | Triterpen-derivate und heilmittel fur lebererkrankungen | |
| BR9101822A (pt) | Compostos,processo para sua producao,produto farmaceutico,processo para sua producao,aplicacao dos ditos compostos,e processos para tratamento de malaria e doencas viroticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |